A 63-year-old man with cirrhosis, hepatocellular carcinoma, and coagulopathy was diagnosed with a sinus venosus atrial septal defect (ASD) and partial anomalous pulmonary venous return (PAPVR) of the right upper pulmonary vein (RUPV). Transcatheter repair by positioning a stent graft in the superior vena cava was planned. Based on three-dimensional (3D) reconstruction of gated cardiac CTA, a 28 mm 3 7 cm Endurant II ® aortic extension stent graft (Medtronic, MN) was chosen. A 3D model printed from the CTA was used to simulate device deployment, demonstrating successful exclusion of the sinus venosus ASD with return of the RUPV to the left atrium (LA). Post simulation, the 3D model was used for informed consent. The patient was then taken to the hybrid operating room. On-table cone beam CT was performed and registered with the CTA images. This enabled overlay of 3D regions of interest to live 2D fluoroscopy. The stent graft was then deployed using 3D regions of interest for guidance. Hemodynamics and angiography demonstrated successful exclusion of the sinus venosus ASD and unobstructed return of RUPV to the LA. This is the first report of comprehensive use of contemporary imaging for planning, simulation, patient consent, and procedural guidance for patient-centered complex structural intervention in repair of sinus venosus ASD with PAPVR. We propose this as a process model for continued innovation in structural interventions.
| I N TR ODU C TI ON
Advances in cardiovascular imaging now provide high resolution threedimensional (3D) data. These may be used as templates for 3D printing and can also be imported into the catheterization lab for live guidance during complex interventions. These innovations enable patientcentered novel structural interventions. We report the first 3D imagefusion-guided transcatheter repair of a sinus venosus atrial septal defect (ASD) in a poor surgical candidate after pre-procedural simulation in a 3D printed model. We describe this process as a template for development of future patient-centered structural interventions ( Figure 1 , Supporting Information Video 1).
| C ASE R EP OR T
A 63-year-old man with cirrhosis, hepatocellular carcinoma, thrombocytopenia, and coagulopathy under consideration for liver transplantation presented with shortness of breath and edema. Transthoracic echocardiography (TTE) showed right ventricular (RV) enlargement, hypokinesis, and left to right shunt through a congenital heart lesion. Cardiac MRI revealed a shunt from the left atrium (LA) to the right atrium (RA) via a superior sinus venosus ASD (length 3.5 cm, area 4.4 cm 2 ).
The right upper pulmonary vein (RUPV) connected to the LA as expected but it also abnormally drained into the superior vena cava (SVC) leading to partial anomalous pulmonary venous return (PAPVR).
The estimated Qp:Qs was 1.9:1. Due to liver failure, surgical repair was a poor option, and a transcatheter approach was developed ( Figure 1 ).
| Pre-procedural 3D planning
Our objective was to exclude the SVC from the LA and the RUPV (by covering the sinus venosus ASD) (Figure 2A and external radial strength of the stent graft to ensure apposition to the proximal SVC. This was expected to prevent residual shunt from the LA, or leak. An important concern was to avoid obstructing the RUPV which could induce segmental pulmonary edema and pulmonary hypertension ( Figure 1A ,B).
Based on these objectives and measurements of the gated cardiac CTA (Figure 2A ), we required a device >4 cm in length to exclude both the RUPV and sinus venosus ASD, but <9 cm to avoid covering the azygos vein or extending into the RA. A diameter of at least 26 mm was required to match the proximal SVC at the floor of the sinus venosus ASD and prevent shunt "endograft leak." To optimize safety, the device would be flexible and conform to the curvature of the SVC. It would use active fixation barbs to prevent embolization (unlike arterial targets, the SVC had no calcifications to ensure stable positioning of the device, and many coverings such as PTFE can be slippery). After reviewing stent grafts from multiple vendors, one device met these conditions: the self-expanding Endurant II ® 28 mm 3 7 cm aortic extension (Medtronic, MN) ( Figure 2B ).
| 3D print test implantation
A 3D model was printed using tissue-mimicking rubber-like material 
| Post-procedure imaging and follow-up
Post-procedure day 1 CTA confirmed that the device remained in appropriate position without evidence of RUPV stenosis ( Figure 3H ).
The risk of thrombosis in a freshly implanted stent was considered higher than the bleeding risk; therefore, the patient was discharged on dual anti-platelet therapy (aspirin and clopidogrel). As our patient lives in another country, he was unable to follow-up with us; on telephonic follow-up, he reported improvement in symptoms at 6 months. TTE in his home country showed normalization of RV volume followed by successful liver transplant shortly after.
| D I SCUSSION
We report the first comprehensive use of contemporary imaging for planning, 3D prototyping and simulation, patient consent, and procedural guidance for a patient-centered complex structural intervention in the transcatheter repair of a sinus venosus ASD with PAPVR. We propose this as a process model for innovation in structural heart interventions ( Figure 1 ).
First, we defined our objectives and boundaries to prevent compli- Despite these limitations, meticulous planning can mitigate the risks of these innovative procedures. Currently, however, we cannot recommend this process for low complexity patients: sinus venosus ASDs with PAPVR are surgically corrected with excellent results, and patients able to tolerate conventional therapies should be treated as such. However, routine use of this technique may be possible in the future as outcomes from more cases are reported.
In conclusion, our process may be optimal to identify innovative but straightforward procedures for high complexity patients with comorbidities that preclude conventional therapies. 
